GTF Group

GTF Group is a biotechnology and healthcare company focused on the development and commercialization of metabolic health solutions, particularly those involving Glucose Tolerance Factor (GTF). The company specializes in utilizing trivalent chromium complexes to enhance insulin sensitivity and improve glucose metabolism in patients with Type 2 diabetes and metabolic syndrome. Their product portfolio includes specialized nutritional supplements and therapeutic formulations designed to mimic or support the body's natural insulin-potentiating mechanisms. GTF Group operates with a focus on evidence-based metabolic interventions, bridging the gap between clinical nutrition and pharmaceutical therapy.